Publication | Open Access
Immune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia Gravis
20
Citations
20
References
2022
Year
This study provides Class IV evidence that patients with MG receiving the mRNA-1273 vaccine did not show clinical worsening after vaccination and that most of the patients achieved high cellular or immune response levels.
| Year | Citations | |
|---|---|---|
Page 1
Page 1